{"classes":[{"categories":[{"measurements":[{"comment":"The upper bound for the confidence interval has not been attained.","groupId":"OG000","lowerLimit":"14.6","upperLimit":"NA","value":"41.9"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"}],"units":"Participants"}],"description":"Duration of response is defined for all evaluable participants (receiving Anakinra alone or in combination with Dexamethasone) who have achieved an objective response as the date at which the participants status was first noted to be MR or better to the date progression is documented or the date of last follow-up.","dispersionType":"95% Confidence Interval","groups":[{"id":"OG000","title":"Anakinra With/Without Dexamethasone"}],"paramType":"MEDIAN","populationDescription":"Participants (receiving Anakinra alone or in combination with Dexamethasone) who achieved a MR or better were analyzed.","reportingStatus":"POSTED","timeFrame":"From first documentation of response to progression or last follow-up (up to 5 years)","title":"Duration of Response","type":"SECONDARY","unitOfMeasure":"months"}